China Pharma Holdings, Inc.
CPHI
$1.50
-$0.0634-4.06%
AMEX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3.07% | 18.95% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.07% | 18.95% | |||
| Cost of Revenue | -20.08% | -16.52% | |||
| Gross Profit | 69.09% | 48.83% | |||
| SG&A Expenses | 116.51% | 125.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.62% | -5.66% | |||
| Operating Income | -10.20% | 22.01% | |||
| Income Before Tax | -9.53% | 22.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.53% | 22.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.53% | 22.27% | |||
| EBIT | -10.20% | 22.01% | |||
| EBITDA | -92.63% | 40.47% | |||
| EPS Basic | 17.80% | 27.58% | |||
| Normalized Basic EPS | 17.82% | 27.57% | |||
| EPS Diluted | 17.80% | 27.58% | |||
| Normalized Diluted EPS | 17.82% | 27.57% | |||
| Average Basic Shares Outstanding | 33.33% | 7.34% | |||
| Average Diluted Shares Outstanding | 33.33% | 7.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||